Niki M - Search Results

1

Identification of DOK genes as lung tumor suppressors.

Berger AH, Niki M, Morotti A, Taylor BS, Socci ND, Viale A, Brennan C, Szoke J, Motoi N, Rothman PB, Teruya-Feldstein J, Gerald WL, Ladanyi M, Pandolfi PP. Berger AH, et al. Among authors: niki m. Nat Genet. 2010 Mar;42(3):216-23. doi: 10.1038/ng.527. Epub 2010 Feb 7. Nat Genet. 2010. PMID: 20139980 Free PMC article.

2

DOK2 inhibits EGFR-mutated lung adenocarcinoma.

Berger AH, Chen M, Morotti A, Janas JA, Niki M, Bronson RT, Taylor BS, Ladanyi M, Van Aelst L, Politi K, Varmus HE, Pandolfi PP. Berger AH, et al. Among authors: niki m. PLoS One. 2013 Nov 8;8(11):e79526. doi: 10.1371/journal.pone.0079526. eCollection 2013. PLoS One. 2013. PMID: 24255704 Free PMC article.

3

Role of Dok-1 and Dok-2 in leukemia suppression.

Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP. Niki M, et al. J Exp Med. 2004 Dec 20;200(12):1689-95. doi: 10.1084/jem.20041306. J Exp Med. 2004. PMID: 15611295 Free PMC article.

4

Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.

Oki S, Limnander A, Yao PM, Niki M, Pandolfi PP, Rothman PB. Oki S, et al. Among authors: niki m. Cell Cycle. 2005 Feb;4(2):310-4. Epub 2005 Feb 4. Cell Cycle. 2005. PMID: 15655368

5

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. Chen Z, et al. Among authors: niki m. Nature. 2005 Aug 4;436(7051):725-30. doi: 10.1038/nature03918. Nature. 2005. PMID: 16079851 Free PMC article.

6

Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice.

Niki M, Nayak MK, Jin H, Bhasin N, Plow EF, Pandolfi PP, Rothman PB, Chauhan AK, Lentz SR. Niki M, et al. Thromb Haemost. 2016 May 2;115(5):969-78. doi: 10.1160/TH15-05-0373. Epub 2016 Jan 21. Thromb Haemost. 2016. PMID: 26790499 Free PMC article.

7

Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.

Ott VL, Tamir I, Niki M, Pandolfi PP, Cambier JC. Ott VL, et al. Among authors: niki m. J Immunol. 2002 May 1;168(9):4430-9. doi: 10.4049/jimmunol.168.9.4430. J Immunol. 2002. PMID: 11970986

8

Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Zhao M, Janas JA, Niki M, Pandolfi PP, Van Aelst L. Zhao M, et al. Among authors: niki m. Mol Cell Biol. 2006 Apr;26(7):2479-89. doi: 10.1128/MCB.26.7.2479-2489.2006. Mol Cell Biol. 2006. PMID: 16537894 Free PMC article.

9

Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5'-phosphatase are required for regulation of CD4+CD25+ T cell development.

Kashiwada M, Cattoretti G, McKeag L, Rouse T, Showalter BM, Al-Alem U, Niki M, Pandolfi PP, Field EH, Rothman PB. Kashiwada M, et al. Among authors: niki m. J Immunol. 2006 Apr 1;176(7):3958-65. doi: 10.4049/jimmunol.176.7.3958. J Immunol. 2006. PMID: 16547230

10

p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).

Di Cristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L, Pandolfi PP. Di Cristofano A, et al. Among authors: niki m. J Exp Med. 2001 Aug 6;194(3):275-84. doi: 10.1084/jem.194.3.275. J Exp Med. 2001. PMID: 11489947 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters